ACCUSTEM SCIENCES, INC.
Income Statement
| Line Item | Jun 2023 | May 2023 | Mar 2023 | Feb 2023 | Dec 2022 | Nov 2022 | Sep 2022 | Aug 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $14.6K | — | $15.6K | — | — | — | $58.3K | — |
| SG&A Expense | $358.2K | — | $817.7K | — | — | — | $840.9K | — |
| Operating Income | $-372.8K | — | $-833.3K | — | — | — | $-899.1K | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-372.8K | — | $-833.3K | — | — | — | $-899.1K | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-372.8K | — | $-833.3K | — | — | — | $-899.1K | — |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.03 | — | $-0.07 | — | — | — | $-0.08 | — |
| EPS (Diluted) | $-0.03 | — | $-0.07 | — | — | — | $-0.08 | — |
| Shares Outstanding (Basic) | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M |
| Shares Outstanding (Diluted) | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |